-
1دورية أكاديمية
المؤلفون: Guzmán-Carreras, Alicia1 (AUTHOR), Vellisca-González, Andrea María1 (AUTHOR), Molina-Puente, Juan Igor2 (AUTHOR), García-Alonso, Rocío2 (AUTHOR), Paz-Cabezas, Mateo3 (AUTHOR), Sánchez-Sauce, Beatriz4 (AUTHOR), Aguilar-Rodríguez, Fernando5 (AUTHOR) fernando.aguilar.rodriguez@gmail.com, Iguarán-Bermúdez, María Del Rosario1 (AUTHOR), Andrès, Emmanuel6 (AUTHOR), Lorenzo-Villalba, Noel6 (AUTHOR) noellorenzo@gmail.com, Méndez-Bailón, Manuel1 (AUTHOR)
المصدر: Journal of Clinical Medicine. Jun2024, Vol. 13 Issue 12, p3485. 14p.
مصطلحات موضوعية: *HEART failure, *SODIUM-glucose cotransporter 2 inhibitors, *OLDER patients, *HEART failure patients, *ALDOSTERONE antagonists, *GLUCOSE transporters, *PROPENSITY score matching, *VENTRICULAR ejection fraction
-
2دورية أكاديمية
المؤلفون: Nakagaito, Masaki1 (AUTHOR) mgaito128@gmail.com, Imamura, Teruhiko1 (AUTHOR) teimamu@med.u-toyama.ac.jp, Ushijima, Ryuichi1 (AUTHOR), Nakamura, Makiko1 (AUTHOR), Kinugawa, Koichiro1 (AUTHOR)
المصدر: Journal of Clinical Medicine. Jun2024, Vol. 13 Issue 11, p3196. 11p.
مصطلحات موضوعية: *HEART failure patients, *SODIUM-glucose cotransporter 2 inhibitors, *SODIUM-glucose cotransporters, *MEDICAL care costs, *TREATMENT effectiveness, *PATIENT readmissions
-
3دورية أكاديمية
المؤلفون: Kuo, Hsiao-Huai1,2,3,4 (AUTHOR), Wang, Kuang-Te5,6 (AUTHOR), Chen, Hsin-Hao6,7,8 (AUTHOR), Lai, Zih-Yin9,10 (AUTHOR), Lin, Po-Lin7,11 (AUTHOR), Chuang, Yung-Jen9,10 (AUTHOR), Liu, Lawrence Yu-Min6,11 (AUTHOR) drlawrenceliu@gmail.com
المصدر: Diabetology & Metabolic Syndrome. 5/22/2024, Vol. 16 Issue 1, p1-10. 10p.
مصطلحات موضوعية: *TYPE 2 diabetes, *SODIUM-glucose cotransporter 2 inhibitors, *HEART failure patients, *DIABETIC acidosis
-
4دورية أكاديمية
المؤلفون: Wood, Nathanael1 (AUTHOR), Straw, Sam2 (AUTHOR), Cheng, Chew W.2 (AUTHOR), Hirata, Yu3 (AUTHOR), Pereira, Marcelo G.1 (AUTHOR), Gallagher, Harrison1 (AUTHOR), Egginton, Stuart1 (AUTHOR), Ogawa, Wataru3 (AUTHOR), Wheatcroft, Stephen B.2 (AUTHOR), Witte, Klaus K.2,4 (AUTHOR), Roberts, Lee D.2 (AUTHOR), Bowen, T. Scott1 (AUTHOR) t.s.bowen@leeds.ac.uk
المصدر: European Journal of Heart Failure. Apr2024, Vol. 26 Issue 4, p925-935. 11p.
مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *HEART failure patients, *SODIUM-glucose cotransporters, *SKELETAL muscle, *TRYPTOPHAN, *VENTRICULAR ejection fraction, *LIQUID chromatography-mass spectrometry, *SKELETAL muscle injuries
-
5دورية أكاديمية
المؤلفون: Klug, E1 (AUTHOR), Rayner, B2 (AUTHOR), Wasserfall, M3 (AUTHOR), Kok, A4 (AUTHOR), Mpe, M5 (AUTHOR), Ruder, S6 (AUTHOR), Mohamed, NA7 (AUTHOR), Webb, D8 (AUTHOR) dawebb@mweb.co.za
المصدر: Journal of Endocrinology, Metabolism & Diabetes of South Africa. Apr2024, Vol. 29 Issue 1, p8-17. 10p.
مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *SODIUM-glucose cotransporters, *CHRONIC kidney failure, *TYPE 2 diabetes, *CARDIOVASCULAR diseases, *HEART failure patients
-
6دورية أكاديمية
المؤلفون: McMurray, John J.V.1 (AUTHOR) john.mcmurray@glasgow.ac.uk, Docherty, Kieran F.1 (AUTHOR) kfdocherty@gmail.com, de Boer, Rudolf A.2 (AUTHOR) r.a.deboer@erasmusmc.nl, Hammarstedt, Ann3 (AUTHOR) ann.hammarstedt@astrazeneca.com, Kitzman, Dalane W.4 (AUTHOR) dkitzman@wakehealth.edu, Kosiborod, Mikhail N.5 (AUTHOR) mkosiborod@saint-lukes.org, Maria Langkilde, Anna3 (AUTHOR), Reicher, Barry6 (AUTHOR) Barry.Reicher@astrazeneca.com, Senni, Michele7 (AUTHOR) msenni@asst-pg23.it, Shah, Sanjiv J.8 (AUTHOR) Sanjiv.shah@northwestern.edu, Wilderäng, Ulrica3 (AUTHOR) ulrica.wilderang@astrazeneca.com, Verma, Subodh9 (AUTHOR) Subodh.Verma@unityhealth.to, Solomon, Scott D.10 (AUTHOR) ssolomon@bwh.harvard.edu
المصدر: Circulation. 3/12/2024, Vol. 149 Issue 11, p825-838. 14p.
مصطلحات موضوعية: *HEART failure, *SODIUM-glucose cotransporter 2 inhibitors, *HEART failure patients, *CLINICAL trials, *DAPAGLIFLOZIN, *VENTRICULAR ejection fraction
-
7دورية أكاديمية
المؤلفون: Zhou, Yisheng1 (AUTHOR), Dai, Min2 (AUTHOR), Huang, Tongmin2 (AUTHOR), Chen, Bangsheng3 (AUTHOR), Xiang, Zhiyi4 (AUTHOR), Tang, Jiawen2 (AUTHOR), Zheng, Meixia5 (AUTHOR), Guo, Luyong6 (AUTHOR)
المصدر: Cardiology. 2024, Vol. 149 Issue 2, p104-116. 13p.
مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *HEART failure patients, *RANDOMIZED controlled trials, *HEART failure, *BODY mass index, *VENTRICULAR ejection fraction, *ALDOSTERONE antagonists
-
8دورية أكاديمية
المؤلفون: Usman, Muhammad Shariq1,2 (AUTHOR), Januzzi, James L.3 (AUTHOR), Anker, Stefan D.4 (AUTHOR), Salman, Ali5 (AUTHOR), Parikh, Puja B.6 (AUTHOR), Adamo, Marianna7 (AUTHOR), Filippatos, Gerasimos8 (AUTHOR), Khan, Muhammad Shahzeb9 (AUTHOR), Lala, Anuradha10 (AUTHOR), Verma, Subodh11 (AUTHOR), Metra, Marco7 (AUTHOR), Butler, Javed12,13 (AUTHOR) butlzih@gmail.com
المصدر: European Journal of Heart Failure. Feb2024, Vol. 26 Issue 2, p373-382. 10p.
مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *GLOBAL longitudinal strain, *VENTRICULAR ejection fraction, *HEART failure, *SODIUM-glucose cotransporters, *HEART failure patients, *CANAGLIFLOZIN
-
9دورية أكاديمية
المؤلفون: Ferreira, João Pedro1,2,3 (AUTHOR) j.ferreira@chru-nancy.fr, Butler, Javed4,5 (AUTHOR), Anker, Stefan D.6,7 (AUTHOR), Januzzi, James L.8 (AUTHOR), Panova‐Noeva, Marina9 (AUTHOR), Reese‐Petersen, Alexander L.10 (AUTHOR), Sattar, Naveed11 (AUTHOR), Schueler, Elke12 (AUTHOR), Pocock, Stuart J.13 (AUTHOR), Filippatos, Gerasimos14 (AUTHOR), Packer, Milton15,16 (AUTHOR), Sumin, Mikhail17 (AUTHOR), Zannad, Faiez2 (AUTHOR)
المصدر: European Journal of Heart Failure. Feb2024, Vol. 26 Issue 2, p274-284. 11p.
مصطلحات موضوعية: *HEART failure, *SODIUM-glucose cotransporter 2 inhibitors, *HEART failure patients, *COLLAGEN, *EMPAGLIFLOZIN, *NATRIURETIC peptides
-
10دورية أكاديمية
المؤلفون: Karakasis, Paschalis1 (AUTHOR) pakar15@hotmail.com, Patoulias, Dimitrios2 (AUTHOR), Giannakoulas, George3 (AUTHOR), Rosenkranz, Stephan4 (AUTHOR), Fragakis, Nikolaos1 (AUTHOR)
المصدر: European Journal of Internal Medicine. Jun2024, Vol. 124, p147-149. 3p.
مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *WEDGES, *HEART failure patients, *CARDIOVASCULAR diseases risk factors